Rodolfo Bordoni
Hematology & Oncology · Atlanta, GANPI 1215915079
Payments from drug & device makers
Across 531 payments — averaging $7568.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Deciphera Pharmaceuticals Inc.$2M
- E.r. Squibb & Sons, L.L.C.$402K
- Merck$400K
- AstraZeneca$273K
- Astellas Pharma Global Development$229K
- G1 Therapeutics, Inc.$189K
- plus $547K from 22 others
Across 2 payments — averaging $328.37 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- F. Hoffmann-la Roche AG$657
What the payments were for
- Consulting fees$37,15023%
- Speaking & faculty fees$107,43567%
- Travel & lodging$11,7137%
- Food & beverage$2,8142%
- Education$740%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Deciphera Pharmaceuticals Inc. | 191 | $1,978,567 |
| E.r. Squibb & Sons, L.L.C. | 23 | $402,188 |
| Merck | 35 | $399,579 |
| AstraZeneca | 68 | $273,197 |
| Astellas Pharma Global Development | 30 | $228,522 |
| G1 Therapeutics, Inc. | 19 | $189,228 |
| Exelixis Inc. | 34 | $115,805 |
| Incyte Corporation | 20 | $90,453 |
| Morphosys AG | 4 | $70,075 |
| Eli Lilly | 6 | $58,694 |
| Seagen Inc. | 25 | $50,351 |
| Amgen | 12 | $48,641 |
| Mirati Therapeutics, Inc. | 16 | $29,910 |
| Pfizer | 7 | $21,676 |
| Johnson & Johnson(2 entities) | 13 | $12,230 |
| Novartis | 3 | $9,818 |
| Genentech USA, Inc. | 6 | $7,949 |
| Janssen Research & Development, LLC | 1 | $7,679 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $6,566 |
| Blueprint Medicines Corporation | 1 | $5,000 |
| Sanofi | 2 | $3,725 |
| Bayer | 2 | $2,700 |
| Astrazeneca UK Limited | 2 | $2,000 |
| Morphosys, US Inc. | 1 | $1,770 |
| Jazz Pharmaceuticals Inc. | 1 | $1,313 |
| Janssen Scientific Affairs, LLC | 1 | $1,010 |
| Pharmacyclics LLC, An Abbvie Company | 1 | $74 |
| Fennec Pharmaceuticals, Inc. | 1 | $25 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,018,744 in reported general payments places this provider in the 95th percentile of 370 hematology & oncology providers in Georgia.
Other hematology & oncology in Atlanta
- Mehmet BilenAtlanta$21.7M
- Ajay NookaAtlanta$19.3M
- Olatunji AleseAtlanta$15.5M
- Jonathon CohenAtlanta$8.7M
- Ticiana LealAtlanta$6.1M
- Conor SteuerAtlanta$4.4M
- Anthony HunterAtlanta$4.3M
- Robert BrownAtlanta$4.2M
- Kristie BlumAtlanta$3.7M
- Zachariah DefilippAtlanta$2.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.